APHA
Back to Annual Meeting Page
 		 
American Public Health Association
133rd Annual Meeting & Exposition
December 10-14, 2005
Philadelphia, PA
 APHA 2005
 
Session: HPV and Cervical Cancer: Women's Educational, Emotional, and Medical Experiences and Needs
3062.0: Monday, December 12, 2005: 8:30 AM-10:00 AM
Oral
HPV and Cervical Cancer: Women's Educational, Emotional, and Medical Experiences and Needs
In the past 20 years, oncogenic (also called high-risk) types of HPV have been linked to cervical cancer. HPV is the most common sexually transmitted infection in the U.S. with about 5.5 million people acquiring genital HPV infection each year. A smaller number (about 10,000) of women who have high-risk types of HPV develop cervical cancer in the U.S. Although HPV is the main causative agent for cervical cancer, little is known about the impact of diagnosis and educational, emotional, and medical needs of women who test positive for HPV. The presentations in this session will provide a basic overview of HPV, information on vaccine acceptability among women, effects of HPV on condom use, and effects of HPV diagnosis.
Learning Objectives: By the end of the session, the participant will be able to (1) provide basic facts on human papillomavirus (HPV); (2) describe the relationship between oncogenic or high-risk types of HPV infection and cervical cancer; (3) discuss emotional and psychosocial effects of HPV positivity; (4) discuss the implications of a potential vaccine; (5) explain knowledge gaps and potential educational solutions; and (6) give an overview of the educational, emotional, and medical needs of women who test positive for HPV.
Moderator(s):Donna H. McCree, PhD, MPH, RPh
8:30 AMBasic facts about human papillomavirus (HPV) and future directions  [ Recorded presentation ]
Heather M. Brandt, PhD, CHES, Patricia A. Sharpe, PhD, MPH, Donna H. McCree, PhD, MPH, RPh
8:45 AMVaccine acceptability and HPV knowledge among high risk human papillomavirus (HR-HPV) + and HR-HPV - women in Oklahoma  [ Recorded presentation ]
Katy Duncan Smith, MS, Robert M. Hamm, PhD, Crystal D. Turner, MPH, Sharon S. Hsieh, MA, Danuta Kasprzyk, PhD, Laura A. Koutsky, PhD, Donna H. McCree, PhD, MPH, RPh
9:00 AMEffect of high risk human papillomavirus (HR-HPV) DNA test result on subsequent condom use  [ Recorded presentation ]
Crystal D. Turner, MPH, Robert M. Hamm, PhD, Katy D. Smith, MS, Sharon S. Hsieh, MA, Donna H. McCree, PhD, MPH, RPh
9:15 AMEmotional reactions and confusion over risk status of women receiving an HPV diagnosis  [ Recorded presentation ]
Ellen M. Daley, PhD, MPH, Karen M. Perrin, PhD, MPH, RN, Robert J. McDermott, PhD, Cheryl Vamos, Trisha E. Mueller, MPH, Holly Rayko, MA, Jennifer L. Packing-Ebuen, MA, Mary McFarlane, PhD
9:30 AMEffects of HPV diagnosis on women’s perceived health risks, pregnancy intentions, and information seeking practices: Implications for educators and practitioners  [ Recorded presentation ]
Ellen M. Daley, PhD, MPH, Karen M. Perrin, PhD, MPH, RN, Robert J. McDermott, PhD, Cheryl Vamos, Trisha E. Mueller, BS, Holly Rayko, MA, Jennifer L. Packing-Ebuen, MA, Mary McFarlane, PhD
See individual abstracts for presenting author's disclosure statement and author's information.
Organized by:Women's Caucus
Endorsed by:APHA-Committee on Women's Rights; Public Health Education and Health Promotion; Socialist Caucus
CE Credits:CME, Health Education (CHES), Nursing

The 133rd Annual Meeting & Exposition (December 10-14, 2005) of APHA